Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
IntroductionConference Proceeding - Introduction

Role of Risk Assessments in Viral Safety: An FDA Perspective

Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson and Patrick Swann
PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 6-10; DOI: https://doi.org/10.5731/pdajpst.2014.00959
Lixin Xu
Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lixin.xu@fda.hhs.gov
Sang Bong Lee
Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chana Fuchs
Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth C. Hyams
Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Brorson
Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Swann
Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 68 no. 1 6-10
DOI 
https://doi.org/10.5731/pdajpst.2014.00959
PubMed 
24504229

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online February 6, 2014.

Copyright & Usage 
© PDA, Inc. 2014

Author Information

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions
    Jarel K. Gandhi, Travis Knudsen, Matthew Hill, Bhaskar Roy, Lori Bachman, Cynthia Pfannkoch-Andrews, Karina N. Schmidt, Muriel M. Metko, Michael J. Ackerman, Zachary Resch, Jose S. Pulido, Alan D. Marmorstein
    Stem Cells Translational Medicine 2019 8 6
  • Integrated viral clearance strategies — reflecting on the present, projecting to the future
    David J Roush
    Current Opinion in Biotechnology 2018 53
  • Plasmon-Enhanced Pan-Microbial Pathogen Inactivation in the Cavitation Regime: Selectivity Without Targeting
    Mina Nazari, Min Xi, Mark Aronson, Oliver Mcrae, Mi K. Hong, Suryaram Gummuluru, Allyson E. Sgro, James C. Bird, Lawrence D. Ziegler, Christopher Gillespie, Kathleen Souza, Nhung Nguyen, Robert M. Smith, Edward Silva, Ayako Miura, Shyamsunder Erramilli, Björn M. Reinhard
    ACS Applied Nano Materials 2019 2 4
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 68 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 68, Issue 1
January/February 2014
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of Risk Assessments in Viral Safety: An FDA Perspective
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Role of Risk Assessments in Viral Safety: An FDA Perspective
Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson, Patrick Swann
PDA Journal of Pharmaceutical Science and Technology Jan 2014, 68 (1) 6-10; DOI: 10.5731/pdajpst.2014.00959

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of Risk Assessments in Viral Safety: An FDA Perspective
Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson, Patrick Swann
PDA Journal of Pharmaceutical Science and Technology Jan 2014, 68 (1) 6-10; DOI: 10.5731/pdajpst.2014.00959
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Proceedings of the 2023 Viral Clearance Symposium, Session 2: Viral Clearance Strategy and Case Studies
  • MIT CAACB Risk Assessment Case Study: Assessing Virus Cross-Contamination Risk between Two Simultaneous Processes in an Open Biomanufacturing Facility
  • Google Scholar

More in this TOC Section

  • Viral Safety Perspective from the Paul-Ehrlich-Institut in Europe
  • Overview of 2009 Indianapolis Conference White Paper: The Goal of an Integrated Viral Clearance Strategy
Show more Conference Proceeding - Introduction

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire